Mối liên quan giữa xơ gan mật nguyên phát và đa hình gen thụ thể vitamin D BsmI trong một quần thể Hungary

Morrison NA, Yeoman R, Kelly PJ, Eisman JA: Contribution of transacting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 89:6665–6669, 1992 Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA: Genetic factors in bone turnover. J Clin Endocrinol Metab 72:808–813, 1991 Nelson DA: The search for the osteoporosis gene. J Clin Endocrinol Metab 82:989–990, 1997 Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 367:284–287, 1994 Need AG, Horowitz M, Stiliano A, Scopacasa F, Morris HA, Chatterton BE: Vitamin D receptor genotypes are related to bone size and bone density in men. Eur J Clin Invest 26:793–796, 1996 Spector TD, Keen RW, Arden NK, Morrison NA, Major PJ, Nguyen TV, Kelly PJ, Baker JR, Sambrook PN, Lanchbury JS, Eisman JA: Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: A twin study in Britain. BMJ 310:1357–1360, 1995 Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour J-P: Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. BMJ 345:423–424, 1995 Tokita A, Matsumoto H, Morrison NA, Tawa T, Miura Y, Fukamauchi K, Mitsuhashi N, Irimoto M, Yamamori S, Miura M, Watanabe T, Kuwabara Y, Yabuta K, Eisman JA: Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 11:1003–1009, 1996 Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B: The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 10:985–990, 1995 Jorgensen HL, Scholler J, Sand JC, Bjuring M, Hassager C, Christiansen C: Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: cross sectional and longitudinal population study. BMJ 313:586–590, 1996 Gunnes M, Berg JP, Halse J, Lehmann EH: Lack of relationship between vitamin D receptor genotype and forearm bone gain in healthy children, adolescents and young adults. J Clin Endocrinol Metab 82:851–855, 1997 Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J: Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest 94:2130–2134, 1994 Young RP, Lau EMC, Birjandi Z, Critchley JAJII, Woo J: Interethnic differences in hip fracture rate and the vitamin D receptor polymorphism. Lancet 348:688–689, 1996 Beavan S, Prentice A, Yan L, Dibba B, Ralston S: Differences in vitamin D receptor genotype and geographical variation in osteoporosis. Lancet 348:136–137, 1996 Cooper G, Umbach DM: Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11:1841–1849, 1996 Farrow S: Allelic variation and the vitamin D receptor. Lancet 343:1242, 1994 Mundy GR: Boning up on genes. Nature 367:216–217, 1994 van Leeuwen JPTM, Uitterlinden AG, Birkenhager JC, Pols HAP: Vitamin D receptor gene polymorphisms and osteoporosis. Steroids 61:154–156, 1996 Dawson-Hughes B, Harris SS, Finneran S: Calcium absorption on high and low calcium intake in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80:3657–3661, 1995 Wishart JM, Horowitz M, Need AG, Scopacasa F, Morris HA, Clifton PM, Nordin BE: Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene and calcium absorption in premenopausal women. Am J Clin Nutr 65:798–802, 1997 Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, Kelly PJ: Genetic influences on bone density: Physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 80:2800–2805, 1995 Park BS, Park JS, Lee DY, Youn JI, Kim IG: Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol 112:113–116, 1999 Bellamy R, Ruwnede C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV: Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 179:721–724, 1999 Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV: Association of vitamin D receptor genotype with leprosy type. J Infect Dis 179:187–191, 1999 Laurin JM, Lindor KD: Primary biliary cirrhosis. Dig Dis 12:331–350, 1994 Heathcote J: Treatment of primary biliary cirrhosis. J Gastroenterol Hepatol 11:605–609, 1996 Lindor KD: Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis. Semin Liver Dis 13:367–373, 1993 Crippin JS, Jorgensen RA, Dickson ER, Lindor KD: Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 89:47–50, 1994 Reichel H, Koeffler HP, Norman AW: The role of vitamin D endocrine system in health and disease. N Engl J Med 320:980–991, 1989 Casteels K, Bouillon R, Waer M, Mathieu C: Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Curr Opin Nephrol Hypertens 4:313–318, 1995 Manolagas SC, Yu XP, Girasole G, Bellido T: Vitamin D and the hematolymphopoietic tissue: A 1994 update. Semin Nephrol 14:129–143, 1994 Buts JP, DeKeyser N, Collette E, Bonsignore M, Lambotte L, Desjeux JF, Sokal EM: Intestinal transport of calcium in rat biliary cirrhosis. Pediatr Res 40:533–541, 1996 Mehal WZ, Gregory WL, Lo YM, Cross SJ, Fleming KA, Bassendine MF, James OF, Campbell RD, Chapman RW, Rosenberg WM: Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology 20:1213–1219, 1994 Agarwal K, Jones DE, Bassendine MF: Genetic susceptibility to primary biliary cirrhosis. Eur J Gastroenterol Hepatol 11:603–606, 1999 Mella JG, Roschmann E, Maier KP, Volk BA: Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population. Hepatology 21:398–402, 1995 Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D: Primary biliary cirrhosis shows an association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol 31:242–247, 1999 Yu XP, Hustmyer FG, Garvey WT, Manolagas SC: Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: immunologic crossreactivity and inverse regulation with the vitamin D receptor. Proc Natl Acad Sci USA 88:8347–8351, 1991 Muller K, Svenson M, Bendtzen K: 1 alpha,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro. Immunol Lett 17:361–365, 1988 Riancho JA, Zarrabeitia MT, de Francisco AL, Amado JA, Napal J, Arias M, Gonzalez-Macias J: Vitamin D therapy modulates cytokine secretion in patients with renal failure. Nephron 65:364–368, 1993 Clavreul A, D'hellencourt CL, Montero-Menei C, Potron G, Couez D: Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology 95:272–277, 1998 Kitajima I, Maruyama I, Matsubara H, Osame M, Igata A: Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: Immunoregulatory reaction of 1 alpha(OH) vitamin D3. Clin Immunol Immunopathol 53:24–31, 1989 Lemire JM, Archer DC, Reddy GS: 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135:2818–2821, 1994 Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R: Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diabetologia 37:552–558, 1994 EURODIAB Substudy 2 Study Group: Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42:51–54, 1999